» Articles » PMID: 25169110

Fisetin Inhibits UVB-induced Cutaneous Inflammation and Activation of PI3K/AKT/NFκB Signaling Pathways in SKH-1 Hairless Mice

Overview
Date 2014 Aug 30
PMID 25169110
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Solar ultraviolet B (UVB) radiation has been shown to induce inflammation, DNA damage, p53 mutations and alterations in signaling pathways eventually leading to skin cancer. In this study, we investigated whether fisetin reduces inflammatory responses and modulates PI3K/AKT/NFκB cell survival signaling pathways in UVB-exposed SKH-1 hairless mouse skin. Mice were exposed to 180 mJ cm(-2) of UVB radiation on alternate days for a total of seven exposures, and fisetin (250 and 500 nmol) was applied topically after 15 min of each UVB exposure. Fisetin treatment to UVB-exposed mice resulted in decreased hyperplasia and reduced infiltration of inflammatory cells. Fisetin treatment also reduced inflammatory mediators such as COX-2, PGE2 as well as its receptors (EP1-EP4) and MPO activity. Furthermore, fisetin reduced the level of inflammatory cytokines TNFα, IL-1β and IL-6 in UVB-exposed skin. Fisetin treatment also reduced cell proliferation markers as well as DNA damage as evidenced by increased expression of p53 and p21 proteins. Further studies revealed that fisetin inhibited UVB-induced expression of PI3K, phosphorylation of AKT and activation of the NFκB signaling pathway in mouse skin. Overall, these data suggest that fisetin may be useful against UVB-induced cutaneous inflammation and DNA damage.

Citing Articles

The Effects of Novel Co-Amorphous Naringenin and Fisetin Compounds on a Diet-Induced Obesity Murine Model.

Vasquez-Reyes S, Bernal-Gamez M, Dominguez-Chavez J, Mondragon-Vasquez K, Sanchez-Tapia M, Ordaz G Nutrients. 2025; 16(24.

PMID: 39771046 PMC: 11678459. DOI: 10.3390/nu16244425.


Radiation dermatitis in the hairless mouse model mimics human radiation dermatitis.

Lawrence J, Seelig D, Demos-Davies K, Ferreira C, Ren Y, Wang L Sci Rep. 2024; 14(1):24819.

PMID: 39438583 PMC: 11496547. DOI: 10.1038/s41598-024-76021-9.


P2RY6 deletion promotes UVB-induced skin carcinogenesis by activating the PI3K/AKT signal pathway.

Xu P, Liu T, Yang Z, Zang K, Gao X, Shi Y Cancer Sci. 2024; 116(1):56-66.

PMID: 39435731 PMC: 11711044. DOI: 10.1111/cas.16378.


miR-338-5p regulated the NF-κB/MAPK pathway to alleviate inflammation and oxidative stress by targeting IL-6 in rats with atrial fibrillation.

Zhang Y, Yao Y, Wei J, Zhang Z 3 Biotech. 2024; 14(7):182.

PMID: 38947734 PMC: 11213847. DOI: 10.1007/s13205-024-04024-4.


Exogenous Nucleotides Improve the Skin Aging of SAMP8 Mice by Modulating Autophagy through MAPKs and AMPK Pathways.

Fan R, Zhang Y, Liu R, Wei C, Wang X, Wu X Nutrients. 2024; 16(12).

PMID: 38931262 PMC: 11206724. DOI: 10.3390/nu16121907.


References
1.
Vaid M, Sharma S, Katiyar S . Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. Carcinogenesis. 2010; 31(11):2004-11. DOI: 10.1093/carcin/bgq186. View

2.
Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A . PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 2008; 22(18):2496-506. PMC: 2546691. DOI: 10.1101/gad.1676108. View

3.
Bashir M, Sharma M, Werth V . UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol. 2008; 129(4):994-1001. PMC: 3345265. DOI: 10.1038/jid.2008.332. View

4.
Afaq F . Natural agents: cellular and molecular mechanisms of photoprotection. Arch Biochem Biophys. 2010; 508(2):144-51. PMC: 3060948. DOI: 10.1016/j.abb.2010.12.007. View

5.
Bachelor M, Cooper S, Sikorski E, Timothy Bowden G . Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase decreases UVB-induced activator protein-1 and cyclooxygenase-2 in a SKH-1 hairless mouse model. Mol Cancer Res. 2005; 3(2):90-9. DOI: 10.1158/1541-7786.MCR-04-0065. View